Eleni Chantzoura

Medicine · Health Sciences

6h-index287citations21works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(11), Immune Cell Function and Interaction(10), Pluripotent Stem Cells Research(5), Immunotherapy and Immune Responses(5), CRISPR and Genetic Engineering(5)

Publications21 total

Figure S4 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Data from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
Table S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026Open Access
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
Cancer Immunology Research·2025
CAR-iNKT cells: redefining the frontiers of cellular immunotherapy
Frontiers in Immunology·2025· 7 citedOpen Access
753 AgenT-797 cell therapy can be combined with next-generation immune checkpoint inhibitors (ICI) and/or bi-specific engagers to improve anti-cancer response
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
374 PRAME-TCR iNKT cell therapy: opportunity for best-in-class off-the-shelf solid tumor therapy targeting PRAME
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Abstract 1331: MiNK-215, an IL-15 armored FAP-targeting CAR iNKT cell therapy, effectively treats human organoid models of treatment-refractory MSS colorectal cancer (CRC) liver metastases
Cancer Research·2024· 2 cited
iNKT cells for allogeneic cell therapy
Cell and Gene Therapy Insights·2023
Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
Nature Communications·2023· 1 citedOpen Access
Molecular mechanism of phosphopeptide neoantigen immunogenicity
Nature Communications·2023· 17 citedOpen Access
322 MiNK-413: a next generation armored allogenic BCMA CAR iNKT product
Regular and Young Investigator Award Abstracts·2022· 2 citedOpen Access
358 Development of an allogenic FAP CAR iNKT product to target tumor stroma and modulate the tumor microenvironment
Regular and Young Investigator Award Abstracts·2022· 2 citedOpen Access
135 Identification and characterization of an allogeneic iNKT-CAR targeting BCMA
Regular and Young Investigator Award Abstracts·2021Open Access
164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing
Regular and Young Investigator Award Abstracts·2020· 2 citedOpen Access
Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming
Cell stem cell·2017· 48 citedOpen Access
Flow Cytometry
Elsevier eBooks·2017· 9 cited
List of Contributors
Elsevier eBooks·2017
Reprogramming Roadblocks Are System Dependent
Stem Cell Reports·2015· 38 citedOpen Access
Novel tools to discern the pluripotency gene network establishment
Transgenic Research·2014
page 1 of 2Next →

Frequent Co-authors

Xavier Michelet(10), Marc Van Dijk(9), Martyna Popis(9), Paul Ibbett(9), Dhan Chand(8), Olivier Le Tonquèze(8), Robert B. Stein(7), Efrat Altman-Sharoni(6), Mark A. Exley(6), Reed Masakayan(6), Shannon K. Boi(6), Justin G. Keith(6), Keisuke Kaji(5), Jin San Choi(5), Stephanie Sanders(5), Nick Kushner(5), Kah Teong Soh(5), Georgios Antonopoulos(5), Anna Johnsson(4), Sten Linnarsson(4)